Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | acrylamide | increases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of ZNF441 mRNA | CTD | PMID:32763439 | aflatoxin B1 | increases methylation | ISO | ZNF441 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of ZNF441 gene | CTD | PMID:28458013 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of ZFP873 mRNA | CTD | PMID:30779732 | benzo[a]pyrene | decreases methylation | ISO | ZNF441 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ZNF441 exon and Benzo(a)pyrene results in decreased methylation of ZNF441 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | ZNF441 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ZNF441 3' UTR | CTD | PMID:27901495 | bisphenol A | increases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of ZNF441 mRNA | CTD | PMID:31715268 | cisplatin | increases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of ZNF441 mRNA | CTD | PMID:27594783 | dorsomorphin | multiple interactions | ISO | ZNF441 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ethyl methanesulfonate | increases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of ZNF441 mRNA | CTD | PMID:23649840 | formaldehyde | increases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of ZNF441 mRNA | CTD | PMID:23649840 | hydralazine | multiple interactions | ISO | ZNF441 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ZNF441 mRNA | CTD | PMID:17183730 | leflunomide | increases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | Leflunomide results in increased expression of ZNF441 mRNA | CTD | PMID:28988120 | methyl methanesulfonate | increases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of ZNF441 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of ZNF441 mRNA | CTD | PMID:28001369 | perfluorononanoic acid | increases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of ZNF441 mRNA | CTD | PMID:25812627 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of ZNF441 mRNA | CTD | PMID:27153767 | perfluorooctanoic acid | increases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of ZNF441 mRNA | CTD | PMID:25812627 | quercetin | decreases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of ZNF441 mRNA | CTD | PMID:21632981 | rifampicin | increases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | Rifampin results in increased expression of ZNF441 mRNA | CTD | PMID:24552687 | SB 431542 | multiple interactions | ISO | ZNF441 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | trichostatin A | decreases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of ZNF441 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | ZNF441 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF441 mRNA | CTD | PMID:27188386 | urethane | increases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | Urethane results in increased expression of ZNF441 mRNA | CTD | PMID:28818685 | valproic acid | increases methylation | ISO | ZNF441 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of ZNF441 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | ZNF441 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ZNF441 mRNA | CTD | PMID:23179753 and PMID:26272509 | valproic acid | multiple interactions | ISO | ZNF441 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ZNF441 mRNA more ... | CTD | PMID:17183730 and PMID:27188386 | valproic acid | decreases expression | ISO | Zfp873 (Mus musculus) | 6480464 | Valproic Acid analog results in decreased expression of ZFP873 mRNA and Valproic Acid results in decreased expression of ZFP873 mRNA | CTD | PMID:21427059 | |